[1]
Lazić, J., Kotur, N., Krstovski, N., Dokmanović, L., Zukić, B., Predojević-Samardžić, J., Životić, M., Miločević, G., Đorić, M., Janić, D. and Pavlović, S. 2017. Importance of pharmacogenetic markers in the methylenetetrahydrofolate reductase gene during methotrexate treatment in pediatric patients with acute lymphoblastic leukemia. Archives of Biological Sciences. 69, 2 (May 2017), 239–246.